Introduction: Who Should Undergo Diagnostics and When
B-cell small lymphocytic lymphoma, often called SLL, is a slow-growing type of blood cancer that develops from white blood cells known as B lymphocytes. These cells are an important part of the immune system, helping the body fight off infections. In SLL, these B cells become abnormal and grow uncontrollably, primarily affecting the lymph nodes, spleen, and other parts of the lymphatic system. Because SLL grows slowly, many people may live with the condition for years without noticing any symptoms at all.[1][2]
Sometimes, people with SLL only discover they have the disease during routine medical checkups or tests performed for completely unrelated health concerns. This happens because the disease can remain silent for a long time, not causing discomfort or obvious changes in health. When symptoms do appear, they might include painless swelling of lymph nodes in the neck, underarms, or groin, persistent fatigue, night sweats that drench clothing and bedding, and unexplained weight loss.[3][5]
If you notice swollen lymph nodes that don’t go away after a few weeks, experience severe fatigue that doesn’t improve with rest, or develop night sweats and weight loss without a clear reason, it’s important to see a healthcare provider. These symptoms don’t automatically mean you have SLL, as they can be caused by many other conditions, including infections. However, they are important signals that warrant medical attention and further investigation.[3]
Healthcare professionals often recommend diagnostic testing when a physical examination reveals enlarged lymph nodes or an enlarged spleen or liver. Blood tests showing unusually high levels of certain white blood cells might also prompt further testing. People over the age of 60 are at higher risk for SLL, as this disease typically affects older adults, with the average diagnosis occurring around age 65.[21]
Diagnostic Methods
Diagnosing B-cell small lymphocytic lymphoma involves several steps, starting with a careful physical examination and progressing to more detailed tests. The goal is to confirm whether cancer cells are present, determine where they are located in the body, and understand how the disease might behave. This information helps doctors create the most appropriate treatment plan for each person.[9]
Physical Examination
The diagnostic process typically begins with a thorough physical exam. During this exam, your healthcare provider will carefully check for swollen lymph nodes in your neck, underarms, and groin. They will also feel your abdomen to see if your spleen or liver is enlarged. An enlarged spleen or liver can be a sign that lymphoma cells have spread to these organs. Your doctor will also ask about your symptoms, medical history, and any health problems that run in your family.[9][20]
Blood Tests
Blood tests play a crucial role in diagnosing SLL. Several different types of blood tests may be ordered to get a complete picture of what’s happening in your body.[9][20]
A complete blood count, or CBC, measures the number and types of cells in your blood. In people with SLL, this test often shows a high number of B cells, which are a specific type of white blood cell. The CBC also checks levels of red blood cells, which carry oxygen throughout your body, and platelets, which help your blood clot. Low levels of these cells can indicate that lymphoma is affecting the bone marrow.[9][20]
Another blood test called a peripheral blood smear allows doctors to look at your blood cells under a microscope. This test helps them see the size, shape, and appearance of the cells. In SLL, the smear may show many small, round lymphocytes. Sometimes these cells appear damaged or broken on the slide and are called smudge cells, which is a characteristic feature that can help confirm the diagnosis.[9][20]
Blood tests may also measure levels of lactate dehydrogenase, or LDH, an enzyme that is often higher in people with lymphoma. Elevated LDH levels can provide additional evidence of cancer and help doctors monitor the disease. Additionally, your healthcare provider might order tests to check for certain viruses, including HIV, hepatitis B, and hepatitis C. The presence of these viruses can affect treatment choices and outcomes.[9][20]
Lymph Node Biopsy
A biopsy is a procedure where a small sample of tissue is removed from the body and examined in a laboratory. For SLL, doctors often perform a lymph node biopsy to look for cancer cells. This is one of the most important tests for confirming the diagnosis. During a lymph node biopsy, a surgeon removes all or part of an enlarged lymph node. If symptoms suggest that lymphoma has spread to other parts of the body, tissue samples may be taken from those areas as well.[9][20]
In the laboratory, specialists examine the tissue sample under a microscope to see if it contains lymphoma cells. They also perform additional tests on the cells to understand their characteristics. These tests can reveal specific markers on the surface of the cells, which help distinguish SLL from other types of lymphoma and guide treatment decisions.[9][20]
Imaging Tests
Imaging tests create pictures of the inside of your body, allowing doctors to see the size and location of tumors and determine whether lymphoma has spread to other organs. Several different types of imaging tests may be used in diagnosing SLL.[9][20]
A computed tomography scan, or CT scan, uses X-rays and computer technology to produce detailed, three-dimensional images of your body. CT scans can show enlarged lymph nodes in your chest, abdomen, or pelvis, as well as changes in your spleen, liver, or other organs. This test helps doctors understand how widespread the lymphoma is and whether it has affected areas that can’t be felt during a physical exam.[9][20]
A positron emission tomography scan, or PET scan, is another type of imaging test that may be used. During a PET scan, a small amount of radioactive sugar is injected into a vein. Cancer cells tend to absorb more of this sugar than normal cells, making them light up on the scan images. PET scans can help doctors identify active lymphoma cells and assess how well treatment is working.[9][20]
Magnetic resonance imaging, or MRI, uses powerful magnets and radio waves to create detailed images of soft tissues in the body. MRI scans are particularly useful for examining the brain and spinal cord if there is concern that lymphoma has spread to these areas. Ultrasound, which uses sound waves to create images, may also be used to examine the abdomen and check for enlarged organs or lymph nodes.[9][20]
Bone Marrow Examination
In some cases, doctors may recommend a bone marrow biopsy to check whether lymphoma cells have spread to the bone marrow, the soft, spongy tissue inside bones where blood cells are made. During this procedure, a needle is inserted into the hipbone or another large bone to remove a small sample of bone marrow. The sample is then examined under a microscope to look for abnormal cells. A bone marrow biopsy can provide important information about the extent of the disease and help guide treatment planning.[9][20]
Diagnostics for Clinical Trial Qualification
Clinical trials are research studies that test new treatments or combinations of treatments to find better ways to manage diseases like SLL. Participating in a clinical trial can give patients access to cutting-edge therapies that are not yet widely available. However, not everyone with SLL will qualify for every clinical trial. Each study has specific requirements, called eligibility criteria, that determine who can participate.[14]
Before enrolling in a clinical trial, patients typically undergo a comprehensive set of diagnostic tests. These tests serve two main purposes: they confirm the diagnosis and characteristics of the lymphoma, and they ensure that the patient meets the specific criteria set by the researchers conducting the trial. Understanding what these tests involve can help patients prepare for the possibility of joining a clinical trial.[14]
Confirming the Diagnosis
Clinical trials for SLL generally require participants to have a confirmed diagnosis based on standard diagnostic methods. This usually means having had a lymph node biopsy or bone marrow biopsy that showed evidence of small lymphocytic lymphoma. The tissue samples may need to be reviewed again by a pathologist associated with the trial to ensure they meet the study’s definition of SLL. Some trials may also require specific molecular or genetic testing on the biopsy samples to identify certain characteristics of the cancer cells.[12][14]
Determining Disease Stage and Extent
Most clinical trials have requirements about the stage or extent of the disease. Staging describes how much lymphoma is present in the body and where it is located. To determine this, patients may need to undergo imaging tests such as CT scans or PET scans. Blood tests, including complete blood counts and measurements of LDH levels, are also commonly required. These tests help researchers understand the severity of the disease and ensure that participants in the study have similar levels of illness, which makes it easier to evaluate whether the new treatment is effective.[9][12][14]
Assessing Overall Health and Organ Function
Clinical trials need to ensure that participants are healthy enough to tolerate the treatment being tested. This means that patients must undergo tests to assess their overall health and the function of major organs. Blood tests can measure how well the kidneys and liver are working, as these organs are responsible for processing and eliminating medications from the body. Heart function may be evaluated with an electrocardiogram (ECG) or an echocardiogram, which use electrical signals or sound waves to create images of the heart. Lung function tests might also be required, especially if the trial involves treatments that could affect breathing.[14]
Special Laboratory Tests
Certain clinical trials may require more specialized laboratory tests. For example, some studies look for specific genetic changes or markers in the lymphoma cells that might predict how the disease will behave or how well it will respond to treatment. These tests might include analyzing the chromosomes of the cancer cells or checking for mutations in particular genes. While not all SLL patients will need these tests for standard care, they may be essential for qualifying for specific trials that target patients with certain genetic profiles.[12][14]
Another important test that may be used in clinical trials is called flow cytometry. This test examines cells in the blood or bone marrow to look for specific proteins on their surface. In SLL, cancer cells have characteristic patterns of these surface proteins that distinguish them from normal cells and from other types of lymphoma. Flow cytometry helps confirm the diagnosis and can also be used to monitor how well treatment is working during the trial.[12]
Monitoring During the Trial
Once enrolled in a clinical trial, patients undergo regular diagnostic tests to monitor their response to treatment and watch for any side effects. These tests are similar to those used for initial diagnosis but are repeated at specific intervals throughout the study. Blood tests, imaging scans, and sometimes repeat biopsies help researchers track whether the lymphoma is shrinking, staying the same, or growing. This careful monitoring ensures patient safety and provides valuable information about whether the new treatment is working.[14]
